HeartSciences Inc. Stock

HSCS

US42254E3027

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2026-10-15 EDT			5-day change	1st Jan Change
3.180 ^USD	+5.30%		+4.61%	+2.91%

10-06	HeartSciences Inc. Receives FDA 510(k) Clearance for its MyoVista wavECG Device	CI
10-06	Top Premarket Decliners	MT

Latest news: HeartSciences Inc.

10-06	HeartSciences Inc. Receives FDA 510(k) Clearance for its MyoVista wavECG Device	CI
10-06	Top Premarket Decliners	MT
10-02	HeartSciences Inc. Announces Amendment to Loan Agreement Extending Maturity and Outlining Payment Terms	CI
09-23	HeartSciences' Merger Partner Fortitude Upsizes DCG Credit Facility to $50 Million	MT
09-14	HeartSciences Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
07-23	HeartSciences Inc. Reports Earnings Results for the Full Year Ended April 30, 2026	CI
07-22	HeartSciences Inc. Auditor Raises 'Going Concern' Doubt	CI
06-23	Fortitude Mining Holdings, Inc. entered into a definitive merger agreement to acquire HeartSciences Inc. in a reverse merger transaction.	CI
06-23	Top Midday Gainers	MT
06-23	HeartSciences to Merge With Digital Asset Mining Platform Fortitude; Shares Rise Pre-Bell	MT
06-11	HeartSciences Granted European Patent for Electrocardiography Technology; Shares Fall	MT
06-02	HeartSciences Launches MyoVista Insights Version 1.3 With AI-ECG Algorithm Marketplace And First FDA-Cleared Algorithm	CI
05-19	Heartsciences Signs Commercial Agreement with North Shore Health	CI

More news

Analysts' recommendations: HeartSciences Inc.

23-01-30	Ascendiant Capital Initiates Heart Test Laboratories at Buy Rating With $3.30 Price Target	MT
22-12-19	Maxim Adjusts Heart Test Laboratories' Price Target to $3 From $8, Keeps Buy Rating	MT
22-11-09	Maxim Starts Heart Test Laboratories at Buy With $8 Price Target	MT
22-08-08	Benchmark Starts Heart Test Laboratories at Speculative Buy With $8 Price Target	MT

More recommendations

Press Releases: HeartSciences Inc.

10-06	Fortitude Secures Priority Supply Allocation for BITMAIN's Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of DCG Credit Facility and Available ZEC Funding from DCG	AQ
10-06	HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device	AQ
10-05	Fortitude Secures Priority Supply Allocation for BITMAIN’s Next-Generation Zcash Mining Equipment, Announces $100 Million Non-Binding Purchase Commitment, and Additional Upsizing of DCG Credit Facility and Available ZEC Funding from DCG	BU
09-29	Fortitude Appoints Kimberly Pittman as Chief Legal Officer	BU
09-23	Fortitude Announces Amendment to Existing DCG Credit Facility, Increasing Commitment by $24 Million and Providing for Future Funding in ZEC	BU

More press releases

Managers and Directors: HeartSciences Inc.

Manager	Title	Age	Since
Andrew Simpson CEO	Chief Executive Officer	57	2022-02-28
Danielle Watson DFI	Director of Finance/CFO	44	2022-03-31
Aaron Peterson CTO	Chief Tech/Sci/R&D Officer	-	2014-06-30

Director	Title	Age	Since
Andrew Simpson CHM	Chairman	57	2013-05-31
Brian Szymczak BRD	Director/Board Member	54	2013-12-31
Bruce Bent BRD	Director/Board Member	70	2020-04-30

More insiders

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-10-15	US$3.180	+5.30%	71,604
26-10-14	US$3.020	-2.27%	85,708
26-10-13	US$3.090	-6.36%	90,710
26-10-12	US$3.300	+3.77%	58,040
26-10-09	US$3.180	+4.61%	109,299

Delayed Quote Nasdaq

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

3.180USD

Average target price

12.00USD

Spread / Average Target

+277.36%

Consensus

EPS Estimates

Evolution of Analysts' Estimates - EPS - HeartSciences Inc.

Revisions to estimates

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - HeartSciences Inc.

Company calendar

Market Cap	15.26M 13.63M 12.66M 11.52M 21.67M 1.45B 22.06M 152M 59.52M 754M 57.28M 56.07M 2.41B	P/E 2027 *	-1.1x	P/E 2028 *	-1.58x
Enterprise Value	15.26M 13.63M 12.66M 11.52M 21.67M 1.45B 22.06M 152M 59.52M 754M 57.28M 56.07M 2.41B	EV / Sales 2027 *	893x	EV / Sales 2028 *	4.85x
Free-Float	84.35%	Yield 2027 *	-	Yield 2028 *	-

1 day	+5.30%
1 week	+4.61%
Current month	-23.92%
1 month	-7.56%
3 months	+24.22%
6 months	+60.61%
Current year	+2.91%

1 week	2.89	3.42
1 month	2.89	5.25
Current year	1.63	5.25
1 year	1.63	5.25
3 years	1.63	52
5 years	1.63	600
10 years	1.63	600

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/7/26	Danielle Watson	Free	Chief Financial Officer	25,000	0.7598%
1/12/26	David Wells	Free	Director	15,000	0.4720%
1/12/26	Bruce Bent	Free	Director	15,000	0.4720%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
HEARTSCIENCES INC.	+5.30%	+4.61%	-9.40%	-91.53%	14.5M
THERMO FISHER SCIENTIFIC, INC.	+3.46%	+6.83%	+31.94%	+44.25%	249B
DANAHER CORPORATION	+3.03%	+6.46%	+12.32%	+10.54%	158B
INTUITIVE SURGICAL, INC.	+1.81%	+3.00%	-1.78%	+56.64%	148B
BOSTON SCIENTIFIC CORPORATION	+2.65%	+5.00%	-54.83%	-10.86%	62.32B
EDWARDS LIFESCIENCES CORPORATION	+1.91%	+4.58%	+20.80%	+24.47%	49.83B
SIEMENS HEALTHINEERS AG	+1.95%	+6.77%	-13.31%	-14.04%	49.61B
AGILENT TECHNOLOGIES, INC.	+0.89%	+4.39%	+25.71%	+58.85%	49.06B
VEEVA SYSTEMS INC.	+5.27%	+9.90%	+8.93%	+44.85%	48.14B
WATERS CORPORATION	+1.73%	+3.50%	+33.62%	+75.82%	42.9B
Average	+2.63%	+4.03%	+5.40%	+19.90%	85.72B
Weighted average by Cap.	+2.43%	+3.49%	+11.35%	+34.10%

HeartSciences Inc. Stock

Stocks

HSCS

US42254E3027

Advanced Medical Equipment & Technology

Valuation: HeartSciences Inc.

Chart: HeartSciences Inc.

Latest news: HeartSciences Inc.

Analysts' recommendations: HeartSciences Inc.

Press Releases: HeartSciences Inc.

Quotes and Performance

Price Extremes

Managers and Directors: HeartSciences Inc.

Latest insider transactions

Medical Monitoring Systems

Financials

Company Profile

Quotes

Analysts' Consensus

Quarterly revenue - Rate of surprise

	2027 *	2028 *
Net sales	17.1K 15.26K 14.19K 12.9K 24.28K 1.62M 24.71K 170K 66.67K 845K 64.17K 62.81K 2.7M	3.15M 2.81M 2.61M 2.38M 4.47M 298M 4.55M 31.39M 12.28M 156M 11.82M 11.57M 498M
Net income	-12.32M -11M -10.22M -9.3M -17.49M -1.17B -17.8M -123M -48.03M -609M -46.23M -45.25M -1.95B	-10.6M -9.46M -8.79M -8M -15.04M -1B -15.31M -106M -41.31M -524M -39.76M -38.92M -1.68B
Net Debt	-	-

Markets		Quality
Nasdaq	HSCS	Delayed
CBOE	HSCS	Real-time